Dec 19 (Reuters) - Bristol-Myers Squibb Co BMY.N:
BRISTOL MYERS SQUIBB ANNOUNCES AGREEMENT WITH U.S. GOVERNMENT TO IMPROVE AFFORDABILITY AND ACCESS TO CRITICAL MEDICINES FOR AMERICANS
BRISTOL-MYERS SQUIBB CO - ELIQUIS FREE TO MEDICAID STARTING JANUARY 1, 2026
BRISTOL-MYERS SQUIBB CO - BMS TO RECEIVE THREE YEARS OF TARIFF RELIEF
BRISTOL-MYERS SQUIBB CO: SPECIFIC TERMS OF AGREEMENT REMAIN CONFIDENTIAL
BRISTOL-MYERS SQUIBB CO: MEDICINES AVAILABLE AT DISCOUNTS ABOUT 80% OFF CURRENT LIST PRICES
Source text: ID:nBw3tz3H1a
Further company coverage: BMY.N